Last updated: 2026-09-16 09:04:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Caris Life Sciences, Inc. (CAI) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $28.46, with a market capitalisation of $7.36B and a P/E ratio of 76.61. Over the past 52 weeks, its price has ranged from $14.19 to $34.54. This page covers its latest market performance, valuation, price trends and company information.
$7.36B | |
$28.45 | |
$69.18 | |
$4.83 | |
$28.50 | |
3.68K | |
4.44M | |
76.61 | |
$34.54 | |
$14.19 | |
-- | |
-- |
Caris Life Sciences, Inc. (CAI) is trading at $28.46 in pre-market trading as of 2026-09-16 08:45:00, down 0.14% ($0.04) from the previous close of $28.50
Pre-market trading shows how investors are pricing CAI before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Caris Life Sciences, Inc. (CAI) moved from $25.07 to $28.46, representing a gain of 13.53% ($3.39).
The stock traded between $23.20 and $28.68 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 4.20 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.1%
CAI is currently trading at $28.46, placing it 70.1% of the way from its 52-week low of $14.19 to its 52-week high of $34.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1846 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Caris Life Sciences, Inc. (CAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.